Human Adipose Tissue‐Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Stem Cells

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.1881PMID 25376628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty of 1000 evaluation for Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.

  2016cited by this paper
• Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.

  2015cited by this paper
• Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10

  2014cited by this paper
• B cells mediate chronic allograft rejection independently of antibody production.

  2014cited by this paper
• The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation

  2013cited by this paper
• Human follicular dendritic cells promote germinal center B cell survival by providing prostaglandins.

  2013cited by this paper
• IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

  2013cited by this paper
• Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice

  2013cited by this paper
• Sialylation of Campylobacter jejuni Endotoxin Promotes Dendritic Cell–Mediated B Cell Responses through CD14-Dependent Production of IFN-β and TNF-α

  2013cited by this paper
• Mesenchymal stromal cells: sensors and switchers of inflammation.

  2013cited by this paper
• Human Mesenchymal Stem Cells Upregulate CD1dhighCD5+ Regulatory B Cells in Experimental Autoimmune Encephalomyelitis

  2013cited by this paper
• Human adipose‐tissue derived mesenchymal stem cells induce functional de‐novo regulatory T cells with methylated FOXP3 gene DNA

  2013cited by this paper
• Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti‐inflammatory macrophages

  2013cited by this paper
• The BAFF Receptor Transduces Survival Signals by Co-opting the B Cell Receptor Signaling Pathway

  2013cited by this paper
• Mesenchymal Stem Cells Induce an Inflammatory Response After Intravenous Infusion

  2013cited by this paper
• Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

  2012cited by this paper
• IL-2 Requirement for Human Plasma Cell Generation: Coupling Differentiation and Proliferation by Enhancing MAPK–ERK Signaling

  2012cited by this paper
• Late Antibody-Mediated Rejection After Heart Transplantation Following the Development of De Novo Donor-Specific Human Leukocyte Antigen Antibody

  2012cited by this paper
• Mesenchymal stem cell-educated macrophages

  2012cited by this paper
• Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

  2012cited by this paper
• Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells

  2012cited by this paper
• The MSC: an injury drugstore.

  2011cited by this paper
• Mesenchymal stromal cell ‘licensing’: a multistep process

  2011cited by this paper
• The nature of circulating CD27+CD43+ B cells

  2011cited by this paper
• Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology

  2011cited by this paper
• Mesenchymal stem cell effects on T-cell effector pathways

  2011cited by this paper
• B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study.

  2011cited by this paper
• The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy.

  2010cited by this paper
• CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

  2010cited by this paper
• MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

  2009cited by this paper
• Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients

  2009cited by this paper
• Mesenchymal stem cells suppress B-cell terminal differentiation.

  2009cited by this paper
• Regenerative Medicine Applications in Hematology

  2009cited by this paper
• A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation

  2009cited by this paper
• Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

  2008cited by this paper
• APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells.

  2008cited by this paper
• B‐lymphocyte contributions to human autoimmune disease

  2008cited by this paper
• The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

  2008cited by this paper
• Mesenchymal stem cells inhibit natural killer – cell proliferation , cytotoxicity , and cytokine production : role of indoleamine 2 , 3-dioxygenase and prostaglandin E 2

  2008cited by this paper
• Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

  2008cited by this paper
• Regulatory B cells as inhibitors of immune responses and inflammation

  2008cited by this paper
• Donor‐Derived Mesenchymal Stem Cells Remain Present and Functional in the Transplanted Human Heart

  2008cited by this paper
• IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.

  2007cited by this paper
• IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

  2007cited by this paper
• Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.

  2007cited by this paper
• Human Heart, Spleen, and Perirenal Fat-Derived Mesenchymal Stem Cells Have Immunomodulatory Capacities

  2007cited by this paper
• Microenvironmental niches in the bone marrow required for B-cell development

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Mesenchymal stem cells reside in virtually all post-natal organs and tissues

  2006cited by this paper
• Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.

  2005cited by this paper
• Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

  2004cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection1

  2003cited by this paper
• Kidney graft failure and presensitization against HLA Class I and Class II antigens1

  2002cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

  1994cited by this paper
• B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells

  1993cited by this paper
• Antigen‐Presenting Function of B Lymphocytes

  1988cited by this paper
• Induction of CD43 Expression during Activation and Terminal Differentiation of Human B Cells

  1988cited by this paper
• Consequences of the Direct Interaction of Helper T Cells with B Cells presenting Antigen

  1987cited by this paper

• Cell-based Therapies for Burn and Diabetic Wounds Using Mesenchymal Stem Cells: Past, Present, and Future

  2026cites this paper
• Hematopoietic (stem) cells—The elixir of life?

  2025cites this paper
• Macrophage-centred crosstalk with infiltrating immune cells in rheumatoid arthritis and its regulation by mesenchymal stem cells

  2025cites this paper
• Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases

  2025cites this paper
• Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases

  2025cites this paper
• Spatial transcriptomics reveals prognostically LYZ+ fibroblasts and colocalization with FN1+ macrophages in diffuse large B-cell lymphoma

  2025cites this paper
• IFN‐γ Synergizes with TNF‐α to Induce RIPK1‐Independent Necroptosis of Mesenchymal Stem/Stromal Cells

  2025cites this paper
• Is there a path to cure myasthenia gravis?

  2025cites this paper
• Effects of electricity on the regenerative potential of mesenchymal stromal cells and their secretomes

  2025cites this paper
• Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy

  2024cites this paper
• B Cell–mediated Immune Regulation and the Quest for Transplantation Tolerance

  2024cites this paper
• Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?

  2024cites this paper
• Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells by Hydrogel Encapsulation

  2024cites this paper
• International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges

  2024cites this paper
• Basic Science and Principles of Stem Cells, Platelet‐Rich Plasma, and Exosomes

  2024cites this paper
• Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis

  2024cites this paper
• Stem Cell Therapy for SARS-CoV-2 and Influenza Virus Infections

  2024cites this paper
• Advances and clinical challenges of mesenchymal stem cell therapy

  2024cites this paper
• TSG-6 Is Involved in Fibrous Structural Remodeling after the Injection of Adipose-derived Stem Cells

  2024cites this paper
• Exogenous MSC based tissue regeneration: a review of immuno-protection strategies from biomaterial scaffolds.

  2024cites this paper
• Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application.

  2024cites this paper
• Expansion of B10 cells in vitro: Pathways, techniques and applications in transplantation (Review)

  2024cites this paper
• Regulatory B cells in autoimmune diseases: Insights and therapeutic potential.

  2024cites this paper
• Dipeptidyl peptidase-4 marks distinct subtypes of human adipose stromal/stem cells with different hepatocyte differentiation and immunoregulatory properties

  2024cites this paper
• Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility

  2023cites this paper
• Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis

  2023cites this paper
• Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands

  2023cites this paper
• Acoustofluidic Interfaces for the Mechanobiological Secretome of MSCs

  2023cites this paper
• Factors Defining Human Adipose Stem/Stromal Cell Immunomodulation in Vitro

  2023cites this paper
• Timing of Mesenchymal Stromal Cell Therapy Defines its Immunosuppressive Effects in a Rat Lung Transplantation Model

  2023cites this paper
• Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells

  2023cites this paper
• Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren’s syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells

  2023cites this paper
• Interactions of mesenchymal stromal/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis.

  2023cites this paper
• Research Progress in the Treatment of Inflammatory Diseases with Mesenchymal Stem Cells

  2023cites this paper
• The functional effects of Piezo channels in mesenchymal stem cells

  2023cites this paper
• Mesenchymal stem cells influence monocyte/macrophage phenotype: Regulatory mode and potential clinical applications.

  2023cites this paper
• Toward transplantation tolerance with adipose tissue-derived therapeutics

  2023cites this paper
• Immunomodulatory Mechanisms and Therapeutic Potential of Mesenchymal Stem Cells

  2023cites this paper
• Research progress of engineered mesenchymal stem cells and their derived exosomes and their application in autoimmune/inflammatory diseases

  2023cites this paper
• Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis

  2023cites this paper
• Mesenchymal Stromal Cells: Heterogeneity and Therapeutical Applications

  2023cites this paper
• Immunomodulatory Effects of Primed Tonsil-Derived Mesenchymal Stem Cells on Atopic Dermatitis via B Cell Regulation

  2023cites this paper
• Mesenchymal stromal/stem cells and their exosomes application in the treatment of intervertebral disc disease: A promising frontier.

  2022cites this paper
• Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.

  2022cites this paper
• MSCs can be a double-edged sword in tumorigenesis

  2022cites this paper
• Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice

  2022cites this paper
• Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors’ Repertoire in the Recovery of Systemic Lupus Erythematosus

  2022cites this paper
• Bibliometric and visualization analysis of mesenchymal stem cells and rheumatoid arthritis (from 2012 to 2021)

  2022cites this paper
• “Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial”

  2022cites this paper
• Mesenchymal stromal cells induced regulatory B cells are enriched in extracellular matrix genes and IL-10 independent modulators

  2022cites this paper
• Conglomeration of T and B Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells.

  2022cites this paper
• Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances

  2022cites this paper
• Global scientific trends on the immunomodulation of mesenchymal stem cells in the 21st century: A bibliometric and visualized analysis

  2022cites this paper
• Mesenchymal stem cells and their microenvironment

  2022cites this paper
• Potential mesenchymal stem cell therapeutics for treating primary biliary cholangitis: advances, challenges, and perspectives

  2022cites this paper
• Potency assays for human adipose-derived stem cells as a medicinal product toward wound healing

  2022cites this paper
• A Brief Overview of Global Trends in MSC-Based Cell Therapy

  2022cites this paper
• Human Mesenchymal Stem/Stromal Cells in Immune Regulation and Therapy.

  2022cites this paper
• Functional and Immune Modulatory Characteristics of Bone Marrow Mesenchymal Stromal Cells in Patients With Aplastic Anemia: A Systematic Review

  2022cites this paper
• Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy

  2022cites this paper
• Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity

  2022cites this paper
• Sources and Therapeutic Strategies of Mesenchymal Stem Cells in Regenerative Medicine

  2022cites this paper
• Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19

  2022cites this paper
• Mesenchymal Stem Cell–Immune Cell Interaction and Related Modulations for Bone Tissue Engineering

  2022cites this paper
• Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases

  2022cites this paper
• Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management.

  2022cites this paper
• The hematopoietic potential of stem cells from the adipose tissue

  2022cites this paper
• Coaxial nanofibrous scaffolds mimicking the extracellular matrix transition in the wound healing process promoting skin regeneration through enhancing immunomodulation.

  2021cites this paper
• Xenogeneic Humoral Immune Responses to Human Mesenchymal Stem Cells in Mice

  2021cites this paper
• Regulatory B Cell Therapy in Kidney Transplantation

  2021cites this paper
• Curcumin and Mesenchymal Stem Cells Ameliorate Ankle, Testis, and Ovary Deleterious Histological Changes in Arthritic Rats via Suppression of Oxidative Stress and Inflammation

  2021cites this paper
• Stem cell therapy in Alzheimer’s disease

  2021cites this paper
• In Vitro Characterization of Human CD24hiCD38hi Regulatory B Cells Shows CD9 Is Not a Stable Breg Cell Marker

  2021cites this paper
• Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

  2021cites this paper
• sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis

  2021cites this paper
• Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-β1

  2021cites this paper
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy

  2021cites this paper
• From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations

  2021cites this paper
• The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

  2021cites this paper
• Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure

  2021cites this paper
• Taming of Covid-19: potential and emerging application of mesenchymal stem cells

  2021cites this paper
• Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19

  2021cites this paper
• Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

  2021cites this paper
• Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?

  2021cites this paper
• Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation

  2021cites this paper
• Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases

  2021cites this paper
• Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes

  2021cites this paper
• The role of cells and their products in respiratory drug delivery: the past, present, and future

  2020cites this paper
• Mesenchymal stem cells in musculoskeletal tissue engineering

  2020cites this paper
• A Significant Decrease of BAFF, APRIL, and BAFF Receptors Following Mesenchymal Stem Cell Transplantation in Patients with Refractory Rheumatoid Arthritis.

  2020cites this paper
• An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine

  2020cites this paper
• Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery

  2020cites this paper
• Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease

  2020cites this paper
• Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn's Disease: How Colorectal Surgeons Can Help in the COVID-19 Crisis.

  2020cites this paper
• Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application

  2020cites this paper
• Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives

  2020cites this paper
• Stem Cells in Veterinary Medicine—Current State and Treatment Options

  2020influential citation
• B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells

  2020influential citation
• Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus

  2020cites this paper